IL205780A - Synthetic peptides capable of suppressing intravenous production of anti-factor inhibitors viii - Google Patents

Synthetic peptides capable of suppressing intravenous production of anti-factor inhibitors viii

Info

Publication number
IL205780A
IL205780A IL205780A IL20578010A IL205780A IL 205780 A IL205780 A IL 205780A IL 205780 A IL205780 A IL 205780A IL 20578010 A IL20578010 A IL 20578010A IL 205780 A IL205780 A IL 205780A
Authority
IL
Israel
Prior art keywords
vivo
factor viii
synthetic peptides
peptides capable
inhibitor antibodies
Prior art date
Application number
IL205780A
Other languages
English (en)
Hebrew (he)
Other versions
IL205780A0 (en
Original Assignee
Apitope Int Nv
Apitope Technology Bristol Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Apitope Int Nv, Apitope Technology Bristol Ltd filed Critical Apitope Int Nv
Publication of IL205780A0 publication Critical patent/IL205780A0/en
Publication of IL205780A publication Critical patent/IL205780A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745Blood coagulation or fibrinolysis factors
    • C07K14/755Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36Blood coagulation or fibrinolysis factors
    • A61K38/37Factors VIII
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Transplantation (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL205780A 2007-12-04 2010-05-13 Synthetic peptides capable of suppressing intravenous production of anti-factor inhibitors viii IL205780A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0723712.6A GB0723712D0 (en) 2007-12-04 2007-12-04 Peptides
PCT/GB2008/003996 WO2009071886A1 (en) 2007-12-04 2008-12-03 Fviii peptides and their use in tolerising haemophiliacs

Publications (2)

Publication Number Publication Date
IL205780A0 IL205780A0 (en) 2010-11-30
IL205780A true IL205780A (en) 2015-06-30

Family

ID=38982965

Family Applications (1)

Application Number Title Priority Date Filing Date
IL205780A IL205780A (en) 2007-12-04 2010-05-13 Synthetic peptides capable of suppressing intravenous production of anti-factor inhibitors viii

Country Status (25)

Country Link
US (1) US8445448B2 (https=)
EP (1) EP2227488B3 (https=)
JP (2) JP5501245B2 (https=)
KR (1) KR101519840B1 (https=)
CN (2) CN101889024B (https=)
AU (1) AU2008332968B2 (https=)
BR (1) BRPI0820143A2 (https=)
CA (2) CA3005013C (https=)
CY (1) CY1115168T1 (https=)
DK (1) DK2227488T6 (https=)
EA (1) EA019370B1 (https=)
EC (1) ECSP10010327A (https=)
ES (1) ES2458315T7 (https=)
GB (1) GB0723712D0 (https=)
HR (1) HRP20140344T4 (https=)
IL (1) IL205780A (https=)
MX (1) MX2010006084A (https=)
MY (1) MY150995A (https=)
NZ (1) NZ585217A (https=)
PL (1) PL2227488T6 (https=)
PT (1) PT2227488E (https=)
SI (1) SI2227488T1 (https=)
UA (1) UA101003C2 (https=)
WO (1) WO2009071886A1 (https=)
ZA (1) ZA201002997B (https=)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102764425B (zh) 2000-08-21 2015-11-25 阿皮托普技术(布里斯托尔)有限公司 肽选择方法
GB0801513D0 (en) * 2008-01-28 2008-03-05 Circassia Ltd Peptides from factor VIII
EP2300497B1 (en) * 2008-06-24 2012-08-08 Octapharma AG A process of purifying coagulation factor viii
GB0908515D0 (en) * 2009-05-18 2009-06-24 Apitope Technology Bristol Ltd Peptide
CA2765657A1 (en) * 2009-06-16 2010-12-23 Tokai University Anti-gram-negative bacteria agent
EP2632479B1 (en) * 2010-10-27 2017-06-14 Baxalta GmbH Fviii peptides for immune tolerance induction and immunodiagnostics
EA038705B1 (ru) 2012-01-12 2021-10-07 Биовератив Терапьютикс Инк. Способы снижения иммуногенности фактора свёртывания крови viii у пациентов, получающих лечение фактором viii
EA036483B1 (ru) * 2012-11-12 2020-11-16 Эпитоп Интернэшнл Нв Пептиды, способные индуцировать толерантность к рекомбинантному fviii, содержащая их композиция, их применение и способ лечения гемофилии
GB201314052D0 (en) * 2013-08-06 2013-09-18 Apitope Int Nv Peptides
EP4212547A1 (en) 2015-12-03 2023-07-19 Juno Therapeutics, Inc. Modified chimeric receptors and related compositions and methods
JP2019536794A (ja) 2016-12-02 2019-12-19 バイオベラティブ セラピューティクス インコーポレイテッド 凝固因子に対する免疫寛容を誘導する方法
US12077607B2 (en) * 2021-09-23 2024-09-03 University Of Utah Research Foundation Functional and therapeutic effects of PAR4 cleavage by cathepsin G

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE902211A1 (en) * 1989-06-20 1991-01-16 Scripps Clinic Res The phospholipid binding domain of factor viii
WO1998031394A2 (en) * 1997-01-22 1998-07-23 Board Of Regents, The University Of Texas System Tissue factor methods and compositions for coagulation and tumor treatment
CN102764425B (zh) * 2000-08-21 2015-11-25 阿皮托普技术(布里斯托尔)有限公司 肽选择方法
AU2002249779A1 (en) * 2000-12-01 2002-08-12 Regents Of The University Of Minnesota Method to treat hemophilia
CN100522242C (zh) * 2001-02-19 2009-08-05 默克专利有限公司 具有降低的免疫原性的人工蛋白质
WO2002098454A2 (en) 2001-05-31 2002-12-12 D. Collen Research Foundation Vzw Onderwijsen Navorsing Campus Gasthuisberg K.U. Leuven Recombinant molecules with reduced immunogenicity, methods and intermediates for obtaining them and their use in pharmaceutical compositions and diagnostic tools
WO2003087161A1 (en) 2002-04-18 2003-10-23 Merck Patent Gmbh Modified factor viii
HUE027902T2 (en) * 2004-02-09 2016-11-28 Human Genome Sciences Inc Corp Service Company Albumin fusion proteins
WO2006003183A1 (de) 2004-07-02 2006-01-12 Alois Jungbauer Peptide zur blockierung von fviii-inhibitoren
IL229645A0 (en) * 2013-11-26 2014-03-31 Omrix Biopharmaceuticals Ltd A dry bandage containing thrombin and pectin

Also Published As

Publication number Publication date
NZ585217A (en) 2012-11-30
DK2227488T6 (en) 2015-02-16
GB0723712D0 (en) 2008-01-16
JP5501245B2 (ja) 2014-05-21
IL205780A0 (en) 2010-11-30
EA019370B1 (ru) 2014-03-31
ES2458315T3 (es) 2014-04-30
WO2009071886A1 (en) 2009-06-11
CA3005013A1 (en) 2009-06-11
KR101519840B1 (ko) 2015-05-18
EP2227488A1 (en) 2010-09-15
CA2707559A1 (en) 2009-06-11
AU2008332968B2 (en) 2014-03-20
CA3005013C (en) 2021-11-16
ECSP10010327A (es) 2010-09-30
PL2227488T6 (pl) 2015-04-30
SI2227488T1 (sl) 2014-06-30
US8445448B2 (en) 2013-05-21
MY150995A (en) 2014-03-31
MX2010006084A (es) 2010-06-23
EP2227488B3 (en) 2014-11-19
ES2458315T7 (es) 2015-02-18
JP6063402B2 (ja) 2017-01-18
US20100323966A1 (en) 2010-12-23
PT2227488E (pt) 2014-04-21
PL2227488T3 (pl) 2014-07-31
CN103709234B (zh) 2017-01-18
JP2011505414A (ja) 2011-02-24
HRP20140344T1 (en) 2014-05-09
HK1144292A1 (en) 2011-02-11
AU2008332968A1 (en) 2009-06-11
BRPI0820143A2 (pt) 2015-05-12
KR20100087346A (ko) 2010-08-04
EP2227488B1 (en) 2014-01-22
EA201070681A1 (ru) 2010-10-29
CY1115168T1 (el) 2016-12-14
HRP20140344T4 (hr) 2015-07-31
CN103709234A (zh) 2014-04-09
ZA201002997B (en) 2011-07-27
JP2014088440A (ja) 2014-05-15
CA2707559C (en) 2018-07-03
UA101003C2 (uk) 2013-02-25
CN101889024B (zh) 2014-04-23
DK2227488T3 (da) 2014-04-22
CN101889024A (zh) 2010-11-17

Similar Documents

Publication Publication Date Title
IL205780A (en) Synthetic peptides capable of suppressing intravenous production of anti-factor inhibitors viii
IL200030A0 (en) Improvement of protein production
GB0700523D0 (en) The Stabilisation Of Proteins
SI3178490T1 (sl) Sestavki proteina F RSV-ja in postopki za pripravo le-teh
ZA201100290B (en) Soluble canola protein isolate production
ZA201200200B (en) Chimaeric protein
IL236236A (en) Antibodies to the fam26f polypeptide
EP2576593A4 (en) PROCESS FOR THE SYNTHESIS OF DICARBA BRIDGES IN PEPTIDES
IL214375A0 (en) Novel peptides and methods for producing them
GB0920981D0 (en) Peptides
ZA201008279B (en) Novel canola protein isolate
GB0816976D0 (en) Protein
GB0724953D0 (en) Methods of peptide modification
GB0801513D0 (en) Peptides from factor VIII
GB0920987D0 (en) Peptides
GB0707638D0 (en) Methods of manufacture of extended area articles
GB0812586D0 (en) Chimaeric peptide
GB2462726B (en) Protein expression
GB0715325D0 (en) Fertilisation protein
HU0900712D0 (en) New methods and intermediers for the synthesis of ace-inhibitor
GB0817978D0 (en) Peptides
GB0818627D0 (en) Protein
GB0710858D0 (en) Methods for the synthesis of peptides
GB0813006D0 (en) The stabilisation of proteins
IL213454A0 (en) Isolated peptides of rabbit factor v11

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed